

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.20795046 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.11520353 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.11520353 |
| 4 | hemidesmosome assembly (GO:0031581) | 3.95098666 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.68183710 |
| 6 | low-density lipoprotein particle clearance (GO:0034383) | 3.37116717 |
| 7 | desmosome organization (GO:0002934) | 3.29798027 |
| 8 | iron ion import (GO:0097286) | 3.26075799 |
| 9 | protein localization to endosome (GO:0036010) | 3.14332779 |
| 10 | cell adhesion mediated by integrin (GO:0033627) | 3.13279940 |
| 11 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.09973581 |
| 12 | skin morphogenesis (GO:0043589) | 3.08264703 |
| 13 | barbed-end actin filament capping (GO:0051016) | 2.98130708 |
| 14 | negative regulation of complement activation (GO:0045916) | 2.95378487 |
| 15 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.94101267 |
| 16 | endodermal cell differentiation (GO:0035987) | 2.93543029 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.92996180 |
| 18 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.91259352 |
| 19 | surfactant homeostasis (GO:0043129) | 2.85774584 |
| 20 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.79750551 |
| 21 | apoptotic cell clearance (GO:0043277) | 2.78526726 |
| 22 | negative regulation of humoral immune response (GO:0002921) | 2.78096611 |
| 23 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.70340392 |
| 24 | membrane raft organization (GO:0031579) | 2.70337977 |
| 25 | regulation of T cell tolerance induction (GO:0002664) | 2.70135046 |
| 26 | plasma membrane repair (GO:0001778) | 2.70105312 |
| 27 | hepatocyte apoptotic process (GO:0097284) | 2.69720537 |
| 28 | regulation of cholesterol storage (GO:0010885) | 2.66802658 |
| 29 | macroautophagy (GO:0016236) | 2.66247724 |
| 30 | regulation of water loss via skin (GO:0033561) | 2.64551298 |
| 31 | leukocyte aggregation (GO:0070486) | 2.64516756 |
| 32 | negative regulation of protein activation cascade (GO:2000258) | 2.64119418 |
| 33 | skeletal muscle adaptation (GO:0043501) | 2.61784915 |
| 34 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.61123511 |
| 35 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.61057283 |
| 36 | cell-substrate junction assembly (GO:0007044) | 2.59645989 |
| 37 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.59630305 |
| 38 | Golgi transport vesicle coating (GO:0048200) | 2.58526327 |
| 39 | COPI coating of Golgi vesicle (GO:0048205) | 2.58526327 |
| 40 | positive regulation of receptor recycling (GO:0001921) | 2.58012760 |
| 41 | striated muscle atrophy (GO:0014891) | 2.58009325 |
| 42 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.56577146 |
| 43 | regulation of metalloenzyme activity (GO:0048552) | 2.56371430 |
| 44 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.54806861 |
| 45 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.53880844 |
| 46 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.53719480 |
| 47 | keratinocyte proliferation (GO:0043616) | 2.53652813 |
| 48 | establishment of skin barrier (GO:0061436) | 2.53306933 |
| 49 | growth hormone receptor signaling pathway (GO:0060396) | 2.51461307 |
| 50 | regulation of natural killer cell differentiation (GO:0032823) | 2.51365830 |
| 51 | regulation of necroptotic process (GO:0060544) | 2.49568769 |
| 52 | positive regulation of p38MAPK cascade (GO:1900745) | 2.44860648 |
| 53 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.44110492 |
| 54 | wound healing, spreading of epidermal cells (GO:0035313) | 2.44038969 |
| 55 | neutrophil activation involved in immune response (GO:0002283) | 2.43377798 |
| 56 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.43026602 |
| 57 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.42323713 |
| 58 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.42068986 |
| 59 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.41699022 |
| 60 | positive regulation of interferon-alpha production (GO:0032727) | 2.40473745 |
| 61 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.40321310 |
| 62 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.39717583 |
| 63 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.38520672 |
| 64 | cellular response to interferon-alpha (GO:0035457) | 2.38023019 |
| 65 | cellular response to epinephrine stimulus (GO:0071872) | 2.35314092 |
| 66 | collagen fibril organization (GO:0030199) | 2.34967379 |
| 67 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.34841799 |
| 68 | regulation of extracellular matrix disassembly (GO:0010715) | 2.34564865 |
| 69 | regulation of sequestering of triglyceride (GO:0010889) | 2.34077592 |
| 70 | regulation of response to interferon-gamma (GO:0060330) | 2.33670904 |
| 71 | cell-substrate adherens junction assembly (GO:0007045) | 2.33642613 |
| 72 | focal adhesion assembly (GO:0048041) | 2.33642613 |
| 73 | negative regulation of anoikis (GO:2000811) | 2.33175305 |
| 74 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.32957542 |
| 75 | response to epinephrine (GO:0071871) | 2.31212031 |
| 76 | response to laminar fluid shear stress (GO:0034616) | 2.30887411 |
| 77 | regulation of interferon-alpha production (GO:0032647) | 2.28991114 |
| 78 | pinocytosis (GO:0006907) | 2.28733931 |
| 79 | positive regulation of tolerance induction (GO:0002645) | 2.28525141 |
| 80 | membrane protein ectodomain proteolysis (GO:0006509) | 2.26786790 |
| 81 | peptide catabolic process (GO:0043171) | 2.26765889 |
| 82 | epithelial cell-cell adhesion (GO:0090136) | 2.26531154 |
| 83 | regulation of gamma-delta T cell activation (GO:0046643) | 2.26445674 |
| 84 | peptide cross-linking (GO:0018149) | 2.26288904 |
| 85 | negative regulation of fatty acid transport (GO:2000192) | 2.26224605 |
| 86 | stress fiber assembly (GO:0043149) | 2.25875046 |
| 87 | negative regulation of lipid storage (GO:0010888) | 2.24712766 |
| 88 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.24592484 |
| 89 | embryonic process involved in female pregnancy (GO:0060136) | 2.23714798 |
| 90 | negative regulation of protein autophosphorylation (GO:0031953) | 2.23598834 |
| 91 | detection of other organism (GO:0098543) | 2.23533165 |
| 92 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.23514020 |
| 93 | COPII vesicle coating (GO:0048208) | 2.23205787 |
| 94 | regulation of early endosome to late endosome transport (GO:2000641) | 2.23164779 |
| 95 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.21878284 |
| 96 | actin filament-based movement (GO:0030048) | 2.21643835 |
| 97 | renal filtration (GO:0097205) | 2.21299515 |
| 98 | leukocyte cell-cell adhesion (GO:0007159) | 2.21042834 |
| 99 | actin-mediated cell contraction (GO:0070252) | 2.19756957 |
| 100 | multicellular organismal water homeostasis (GO:0050891) | 2.19491867 |
| 101 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.19357873 |
| 102 | regulation of tolerance induction (GO:0002643) | 2.19267051 |
| 103 | mesodermal cell differentiation (GO:0048333) | 2.19101981 |
| 104 | fibril organization (GO:0097435) | 2.18267929 |
| 105 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.17781925 |
| 106 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.17411428 |
| 107 | regulation of anoikis (GO:2000209) | 2.17132539 |
| 108 | sarcomere organization (GO:0045214) | 2.15910402 |
| 109 | muscle atrophy (GO:0014889) | 2.15751451 |
| 110 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.15284083 |
| 111 | cellular response to growth hormone stimulus (GO:0071378) | 2.11646332 |
| 112 | positive regulation of lipid storage (GO:0010884) | 2.10790392 |
| 113 | negative regulation of necroptotic process (GO:0060546) | 2.10696937 |
| 114 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.10587606 |
| 115 | integrin-mediated signaling pathway (GO:0007229) | 2.10343165 |
| 116 | detection of bacterium (GO:0016045) | 2.09469182 |
| 117 | regulation of tight junction assembly (GO:2000810) | 2.09401413 |
| 118 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.08893573 |
| 119 | positive thymic T cell selection (GO:0045059) | 2.08473937 |
| 120 | regulation of necrotic cell death (GO:0010939) | 2.07835172 |
| 121 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.07553691 |
| 122 | negative thymic T cell selection (GO:0045060) | 2.07232869 |
| 123 | fibroblast migration (GO:0010761) | 2.06904769 |
| 124 | response to thyroid hormone (GO:0097066) | 2.06488983 |
| 125 | positive regulation by symbiont of host defense response (GO:0052509) | 2.06181411 |
| 126 | modulation by symbiont of host defense response (GO:0052031) | 2.06181411 |
| 127 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.06181411 |
| 128 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.06181411 |
| 129 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.06181411 |
| 130 | modulation by symbiont of host immune response (GO:0052553) | 2.06181411 |
| 131 | keratinization (GO:0031424) | 2.05716354 |
| 132 | negative T cell selection (GO:0043383) | 2.05338607 |
| 133 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.05034435 |
| 134 | cellular extravasation (GO:0045123) | 2.04814116 |
| 135 | keratan sulfate catabolic process (GO:0042340) | 2.04794476 |
| 136 | chemical homeostasis within a tissue (GO:0048875) | 2.04548418 |
| 137 | muscle filament sliding (GO:0030049) | 2.03701223 |
| 138 | actin-myosin filament sliding (GO:0033275) | 2.03701223 |
| 139 | angiogenesis involved in wound healing (GO:0060055) | 2.03697501 |
| 140 | response to interferon-alpha (GO:0035455) | 2.03649164 |
| 141 | adherens junction assembly (GO:0034333) | 2.03599670 |
| 142 | response to type I interferon (GO:0034340) | 2.03586508 |
| 143 | import into cell (GO:0098657) | 2.03466515 |
| 144 | positive regulation of macrophage differentiation (GO:0045651) | 2.03253223 |
| 145 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.02641462 |
| 146 | heterotypic cell-cell adhesion (GO:0034113) | 2.02384157 |
| 147 | hypotonic response (GO:0006971) | 2.02366555 |
| 148 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.02283934 |
| 149 | actomyosin structure organization (GO:0031032) | 2.02269901 |
| 150 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.02185537 |
| 151 | regulation of integrin activation (GO:0033623) | 2.01908769 |
| 152 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.01478806 |
| 153 | negative regulation of interleukin-12 production (GO:0032695) | 2.01425174 |
| 154 | establishment of endothelial barrier (GO:0061028) | 2.01392842 |
| 155 | positive regulation of reactive oxygen species metabolic process (GO:2000379) | 2.00853092 |
| 156 | glomerular epithelial cell development (GO:0072310) | 2.00184814 |
| 157 | basement membrane organization (GO:0071711) | 2.00114260 |
| 158 | keratinocyte differentiation (GO:0030216) | 2.00102803 |
| 159 | protein hydroxylation (GO:0018126) | 1.99466566 |
| 160 | fatty acid transmembrane transport (GO:1902001) | 1.99267389 |
| 161 | natural killer cell mediated cytotoxicity (GO:0042267) | 1.99128913 |
| 162 | natural killer cell mediated immunity (GO:0002228) | 1.99128913 |
| 163 | cellular response to arsenic-containing substance (GO:0071243) | 1.98455141 |
| 164 | valine metabolic process (GO:0006573) | 1.98081947 |
| 165 | positive regulation of extracellular matrix organization (GO:1903055) | 1.97684955 |
| 166 | regulation of B cell receptor signaling pathway (GO:0050855) | 1.97599432 |
| 167 | actin filament depolymerization (GO:0030042) | 1.97135018 |
| 168 | extracellular fibril organization (GO:0043206) | 1.95362177 |
| 169 | carnitine transmembrane transport (GO:1902603) | 1.95350217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.51204622 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.67597979 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.53440334 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.13955257 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.06315266 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.95580884 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.91203451 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.78929471 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.59979356 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.58666646 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.55269939 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.50407354 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.45540763 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.43089005 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.30795266 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.18857018 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13086332 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.09339622 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.08266812 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.07863546 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.06388273 |
| 22 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.02066499 |
| 23 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.01430463 |
| 24 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98813507 |
| 25 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.97116343 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.91271988 |
| 27 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.82794239 |
| 28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.82439201 |
| 29 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.82198479 |
| 30 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.82115077 |
| 31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78423017 |
| 32 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.75771149 |
| 33 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.75771149 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.75682447 |
| 35 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.68824409 |
| 36 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65239396 |
| 37 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.63331559 |
| 38 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61723175 |
| 39 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.61687432 |
| 40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.58681787 |
| 41 | MYB_26560356_Chip-Seq_TH2_Human | 1.57913512 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.57139851 |
| 43 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.57139449 |
| 44 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56554367 |
| 45 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.55974236 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54953089 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54474462 |
| 48 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.54030856 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.52626249 |
| 50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51643427 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.50261839 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.50065377 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.47026289 |
| 54 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.45664551 |
| 55 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.44664426 |
| 56 | CJUN_26792858_Chip-Seq_BT549_Human | 1.43105838 |
| 57 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40016418 |
| 58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.34913537 |
| 59 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.31836183 |
| 60 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.31426610 |
| 61 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.31258942 |
| 62 | MYB_26560356_Chip-Seq_TH1_Human | 1.29261847 |
| 63 | ATF3_27146783_Chip-Seq_COLON_Human | 1.27840748 |
| 64 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.25241936 |
| 65 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24456815 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24116155 |
| 67 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23674240 |
| 68 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23208000 |
| 69 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22758729 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22442645 |
| 71 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.21040765 |
| 72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.20553716 |
| 73 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.20521372 |
| 74 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.20331951 |
| 75 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.19349772 |
| 76 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18974559 |
| 77 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18545993 |
| 78 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.18074907 |
| 79 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17040476 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16905442 |
| 81 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16784100 |
| 82 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.14694822 |
| 83 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.14694822 |
| 84 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14677472 |
| 85 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.14465958 |
| 86 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.14190070 |
| 87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13837040 |
| 88 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13502766 |
| 89 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12999410 |
| 90 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12503610 |
| 91 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.12497996 |
| 92 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.12301675 |
| 93 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11896184 |
| 94 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11328854 |
| 95 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.11252115 |
| 96 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10550820 |
| 97 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08815794 |
| 98 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08792210 |
| 99 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08748053 |
| 100 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05585857 |
| 101 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05546873 |
| 102 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05435439 |
| 103 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04872174 |
| 104 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04762369 |
| 105 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02729599 |
| 106 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02289790 |
| 107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02289790 |
| 108 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.02113530 |
| 109 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01745820 |
| 110 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.01556588 |
| 111 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.01319354 |
| 112 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01033968 |
| 113 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.00521089 |
| 114 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00442647 |
| 115 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00195379 |
| 116 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.99094968 |
| 117 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.98801774 |
| 118 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98465838 |
| 119 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.98119418 |
| 120 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.97953104 |
| 121 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97900196 |
| 122 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97328099 |
| 123 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.96555843 |
| 124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95949582 |
| 125 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.94229736 |
| 126 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.94052618 |
| 127 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92603107 |
| 128 | MYC_22102868_ChIP-Seq_BL_Human | 0.91115034 |
| 129 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91049855 |
| 130 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.90085950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.54202655 |
| 2 | MP0005275_abnormal_skin_tensile | 3.25163754 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.15073688 |
| 4 | MP0003566_abnormal_cell_adhesion | 2.44647178 |
| 5 | MP0010352_gastrointestinal_tract_polyps | 2.11664841 |
| 6 | MP0003436_decreased_susceptibility_to | 2.09223940 |
| 7 | MP0005451_abnormal_body_composition | 1.97285749 |
| 8 | MP0003300_gastrointestinal_ulcer | 1.93652347 |
| 9 | MP0001835_abnormal_antigen_presentation | 1.92829376 |
| 10 | MP0002166_altered_tumor_susceptibility | 1.83637542 |
| 11 | MP0004947_skin_inflammation | 1.82967064 |
| 12 | MP0002060_abnormal_skin_morphology | 1.82723383 |
| 13 | MP0005023_abnormal_wound_healing | 1.79798515 |
| 14 | MP0003279_aneurysm | 1.79766825 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 1.77712737 |
| 16 | MP0009785_altered_susceptibility_to | 1.76429957 |
| 17 | MP0006054_spinal_hemorrhage | 1.69683410 |
| 18 | MP0000685_abnormal_immune_system | 1.66106935 |
| 19 | MP0000751_myopathy | 1.61281491 |
| 20 | MP0002796_impaired_skin_barrier | 1.60889475 |
| 21 | MP0004036_abnormal_muscle_relaxation | 1.60045296 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.59334132 |
| 23 | MP0005409_darkened_coat_color | 1.54687323 |
| 24 | MP0002006_tumorigenesis | 1.48756336 |
| 25 | MP0005330_cardiomyopathy | 1.46464494 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.45089584 |
| 27 | MP0002877_abnormal_melanocyte_morpholog | 1.44596119 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.44408081 |
| 29 | MP0005165_increased_susceptibility_to | 1.42608803 |
| 30 | MP0000343_altered_response_to | 1.39201600 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.39053673 |
| 32 | MP0003724_increased_susceptibility_to | 1.38976810 |
| 33 | MP0010678_abnormal_skin_adnexa | 1.38523619 |
| 34 | MP0003453_abnormal_keratinocyte_physiol | 1.38280159 |
| 35 | MP0005164_abnormal_response_to | 1.37683323 |
| 36 | MP0001873_stomach_inflammation | 1.37032096 |
| 37 | MP0006138_congestive_heart_failure | 1.36334368 |
| 38 | MP0005000_abnormal_immune_tolerance | 1.35520913 |
| 39 | MP0002419_abnormal_innate_immunity | 1.35286379 |
| 40 | MP0001958_emphysema | 1.35091656 |
| 41 | MP0005025_abnormal_response_to | 1.33678723 |
| 42 | MP0003303_peritoneal_inflammation | 1.32483005 |
| 43 | MP0004272_abnormal_basement_membrane | 1.32043694 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.31345629 |
| 45 | MP0005671_abnormal_response_to | 1.31306404 |
| 46 | MP0001790_abnormal_immune_system | 1.30973166 |
| 47 | MP0005387_immune_system_phenotype | 1.30973166 |
| 48 | MP0003091_abnormal_cell_migration | 1.29283622 |
| 49 | MP0003448_altered_tumor_morphology | 1.28104514 |
| 50 | MP0000013_abnormal_adipose_tissue | 1.27792960 |
| 51 | MP0008260_abnormal_autophagy | 1.27388090 |
| 52 | MP0004185_abnormal_adipocyte_glucose | 1.26379204 |
| 53 | MP0002405_respiratory_system_inflammati | 1.26232005 |
| 54 | MP0004084_abnormal_cardiac_muscle | 1.25756577 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.25165772 |
| 56 | MP0002933_joint_inflammation | 1.25028632 |
| 57 | MP0005503_abnormal_tendon_morphology | 1.24404204 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.23547529 |
| 59 | MP0000858_altered_metastatic_potential | 1.22320726 |
| 60 | MP0001800_abnormal_humoral_immune | 1.21195011 |
| 61 | MP0004484_altered_response_of | 1.21172060 |
| 62 | MP0003828_pulmonary_edema | 1.19236382 |
| 63 | MP0004264_abnormal_extraembryonic_tissu | 1.18286947 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.17994513 |
| 65 | MP0005670_abnormal_white_adipose | 1.17160170 |
| 66 | MP0001243_abnormal_dermal_layer | 1.16966303 |
| 67 | MP0003045_fibrosis | 1.16847943 |
| 68 | MP0004130_abnormal_muscle_cell | 1.16265225 |
| 69 | MP0006082_CNS_inflammation | 1.15402882 |
| 70 | MP0002332_abnormal_exercise_endurance | 1.13715827 |
| 71 | MP0000579_abnormal_nail_morphology | 1.13528199 |
| 72 | MP0005501_abnormal_skin_physiology | 1.13398403 |
| 73 | MP0001851_eye_inflammation | 1.13359239 |
| 74 | MP0001216_abnormal_epidermal_layer | 1.13211836 |
| 75 | MP0002896_abnormal_bone_mineralization | 1.11945410 |
| 76 | MP0000003_abnormal_adipose_tissue | 1.11166280 |
| 77 | MP0008004_abnormal_stomach_pH | 1.10737746 |
| 78 | MP0005257_abnormal_intraocular_pressure | 1.10631110 |
| 79 | MP0005375_adipose_tissue_phenotype | 1.10041472 |
| 80 | MP0005464_abnormal_platelet_physiology | 1.09026853 |
| 81 | MP0005666_abnormal_adipose_tissue | 1.08696966 |
| 82 | MP0002254_reproductive_system_inflammat | 1.07967591 |
| 83 | MP0001819_abnormal_immune_cell | 1.07136926 |
| 84 | MP0002420_abnormal_adaptive_immunity | 1.07074979 |
| 85 | MP0002723_abnormal_immune_serum | 1.06784238 |
| 86 | MP0003763_abnormal_thymus_physiology | 1.06560541 |
| 87 | MP0001845_abnormal_inflammatory_respons | 1.06167601 |
| 88 | MP0001853_heart_inflammation | 1.05579316 |
| 89 | MP0004215_abnormal_myocardial_fiber | 1.05059101 |
| 90 | MP0002972_abnormal_cardiac_muscle | 1.03910958 |
| 91 | MP0001849_ear_inflammation | 1.03598445 |
| 92 | MP0000733_abnormal_muscle_development | 1.02027488 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 1.00000332 |
| 94 | MP0005397_hematopoietic_system_phenotyp | 0.99547049 |
| 95 | MP0001545_abnormal_hematopoietic_system | 0.99547049 |
| 96 | MP0005166_decreased_susceptibility_to | 0.98627257 |
| 97 | MP0004510_myositis | 0.98462621 |
| 98 | MP0002998_abnormal_bone_remodeling | 0.98419977 |
| 99 | MP0005058_abnormal_lysosome_morphology | 0.96295500 |
| 100 | MP0000749_muscle_degeneration | 0.96141130 |
| 101 | MP0009384_cardiac_valve_regurgitation | 0.95623188 |
| 102 | MP0010368_abnormal_lymphatic_system | 0.95579807 |
| 103 | MP0000750_abnormal_muscle_regeneration | 0.93561591 |
| 104 | MP0004087_abnormal_muscle_fiber | 0.92432577 |
| 105 | MP0010307_abnormal_tumor_latency | 0.90894460 |
| 106 | MP0010630_abnormal_cardiac_muscle | 0.90853678 |
| 107 | MP0009840_abnormal_foam_cell | 0.90227067 |
| 108 | MP0004808_abnormal_hematopoietic_stem | 0.89816879 |
| 109 | MP0004883_abnormal_blood_vessel | 0.89776410 |
| 110 | MP0002269_muscular_atrophy | 0.88849578 |
| 111 | MP0005390_skeleton_phenotype | 0.87901588 |
| 112 | MP0003941_abnormal_skin_development | 0.87629297 |
| 113 | MP0000249_abnormal_blood_vessel | 0.87628092 |
| 114 | MP0003950_abnormal_plasma_membrane | 0.87048321 |
| 115 | MP0003183_abnormal_peptide_metabolism | 0.86625385 |
| 116 | MP0000467_abnormal_esophagus_morphology | 0.86115709 |
| 117 | MP0000767_abnormal_smooth_muscle | 0.85638584 |
| 118 | MP0000759_abnormal_skeletal_muscle | 0.85138009 |
| 119 | MP0008469_abnormal_protein_level | 0.84223229 |
| 120 | MP0009278_abnormal_bone_marrow | 0.83610289 |
| 121 | MP0008775_abnormal_heart_ventricle | 0.82181576 |
| 122 | MP0000383_abnormal_hair_follicle | 0.82009012 |
| 123 | MP0000465_gastrointestinal_hemorrhage | 0.81385489 |
| 124 | MP0001879_abnormal_lymphatic_vessel | 0.81308746 |
| 125 | MP0002398_abnormal_bone_marrow | 0.80799231 |
| 126 | MP0004233_abnormal_muscle_weight | 0.80587311 |
| 127 | MP0002837_dystrophic_cardiac_calcinosis | 0.79368306 |
| 128 | MP0009931_abnormal_skin_appearance | 0.79363654 |
| 129 | MP0005623_abnormal_meninges_morphology | 0.79174914 |
| 130 | MP0000716_abnormal_immune_system | 0.78337115 |
| 131 | MP0000762_abnormal_tongue_morphology | 0.77790890 |
| 132 | MP0003075_altered_response_to | 0.77783924 |
| 133 | MP0002971_abnormal_brown_adipose | 0.77412007 |
| 134 | MP0000747_muscle_weakness | 0.77386703 |
| 135 | MP0009764_decreased_sensitivity_to | 0.77198481 |
| 136 | MP0001191_abnormal_skin_condition | 0.76727621 |
| 137 | MP0005360_urolithiasis | 0.76691526 |
| 138 | MP0001544_abnormal_cardiovascular_syste | 0.76437457 |
| 139 | MP0005385_cardiovascular_system_phenoty | 0.76437457 |
| 140 | MP0003186_abnormal_redox_activity | 0.75838901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 3.86805770 |
| 2 | Protrusio acetabuli (HP:0003179) | 3.77953814 |
| 3 | Increased connective tissue (HP:0009025) | 3.72079077 |
| 4 | Premature rupture of membranes (HP:0001788) | 3.51822141 |
| 5 | Eczematoid dermatitis (HP:0000976) | 3.46907943 |
| 6 | Pustule (HP:0200039) | 3.41817465 |
| 7 | Atrophic scars (HP:0001075) | 3.24331336 |
| 8 | Osteolytic defects of the hand bones (HP:0009699) | 3.08960359 |
| 9 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.08960359 |
| 10 | Peritonitis (HP:0002586) | 3.03409162 |
| 11 | Vascular tortuosity (HP:0004948) | 2.98362876 |
| 12 | Arterial tortuosity (HP:0005116) | 2.97541918 |
| 13 | Aortic dissection (HP:0002647) | 2.94685494 |
| 14 | Alopecia of scalp (HP:0002293) | 2.94621055 |
| 15 | Cervical subluxation (HP:0003308) | 2.93309551 |
| 16 | Aortic aneurysm (HP:0004942) | 2.83239325 |
| 17 | Type 1 muscle fiber predominance (HP:0003803) | 2.70867564 |
| 18 | Hyporeflexia of lower limbs (HP:0002600) | 2.70316695 |
| 19 | Ankle contracture (HP:0006466) | 2.70196344 |
| 20 | Myocardial infarction (HP:0001658) | 2.69672603 |
| 21 | Cerebral aneurysm (HP:0004944) | 2.68673312 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 2.64387639 |
| 23 | Ventricular tachycardia (HP:0004756) | 2.63333946 |
| 24 | Thick nail (HP:0001805) | 2.62684650 |
| 25 | Recurrent abscess formation (HP:0002722) | 2.62056840 |
| 26 | Myositis (HP:0100614) | 2.52832657 |
| 27 | Fragile skin (HP:0001030) | 2.52767134 |
| 28 | Nasal polyposis (HP:0100582) | 2.51041051 |
| 29 | Exercise-induced myalgia (HP:0003738) | 2.46472170 |
| 30 | Abnormality of the nasal mucosa (HP:0000433) | 2.44728338 |
| 31 | Broad metatarsal (HP:0001783) | 2.43986611 |
| 32 | Exercise-induced muscle cramps (HP:0003710) | 2.42562463 |
| 33 | Vertebral compression fractures (HP:0002953) | 2.41339791 |
| 34 | Milia (HP:0001056) | 2.35600998 |
| 35 | Distal lower limb muscle weakness (HP:0009053) | 2.35164729 |
| 36 | Dilatation of the ascending aorta (HP:0005111) | 2.32085097 |
| 37 | Bundle branch block (HP:0011710) | 2.31413379 |
| 38 | Malnutrition (HP:0004395) | 2.31117805 |
| 39 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.30074542 |
| 40 | Increased mean platelet volume (HP:0011877) | 2.28318851 |
| 41 | Abnormality of nail color (HP:0100643) | 2.26508028 |
| 42 | Spondylolisthesis (HP:0003302) | 2.23232248 |
| 43 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.22849003 |
| 44 | Recurrent bacterial skin infections (HP:0005406) | 2.21934884 |
| 45 | Orchitis (HP:0100796) | 2.21248631 |
| 46 | Abnormal platelet volume (HP:0011876) | 2.19070812 |
| 47 | Increased variability in muscle fiber diameter (HP:0003557) | 2.18190301 |
| 48 | Muscle fiber splitting (HP:0003555) | 2.17201983 |
| 49 | Difficulty climbing stairs (HP:0003551) | 2.16545543 |
| 50 | Increased IgE level (HP:0003212) | 2.15194833 |
| 51 | Cardiovascular calcification (HP:0011915) | 2.15036705 |
| 52 | Hematochezia (HP:0002573) | 2.12360683 |
| 53 | Facial diplegia (HP:0001349) | 2.07590369 |
| 54 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.06131009 |
| 55 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.06131009 |
| 56 | Abnormality of glycolipid metabolism (HP:0010969) | 2.06131009 |
| 57 | Plantar hyperkeratosis (HP:0007556) | 2.05085103 |
| 58 | Flat acetabular roof (HP:0003180) | 2.04524217 |
| 59 | Asymmetric septal hypertrophy (HP:0001670) | 2.04090080 |
| 60 | Mitral valve prolapse (HP:0001634) | 2.03907140 |
| 61 | Mitral stenosis (HP:0001718) | 2.03792819 |
| 62 | Glucose intolerance (HP:0000833) | 2.02846696 |
| 63 | Lipoatrophy (HP:0100578) | 2.00216245 |
| 64 | Cupped ribs (HP:0000887) | 1.99030636 |
| 65 | Follicular hyperkeratosis (HP:0007502) | 1.98761809 |
| 66 | Interstitial pulmonary disease (HP:0006530) | 1.98102040 |
| 67 | Natal tooth (HP:0000695) | 1.97655962 |
| 68 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.97345126 |
| 69 | Spinal rigidity (HP:0003306) | 1.95943365 |
| 70 | Increased density of long bones (HP:0006392) | 1.95634872 |
| 71 | Neck muscle weakness (HP:0000467) | 1.95627288 |
| 72 | Recurrent fungal infections (HP:0002841) | 1.94918852 |
| 73 | Vascular calcification (HP:0004934) | 1.94096012 |
| 74 | Distal lower limb amyotrophy (HP:0008944) | 1.93878151 |
| 75 | Nemaline bodies (HP:0003798) | 1.92913186 |
| 76 | Arterial thrombosis (HP:0004420) | 1.92646660 |
| 77 | Frequent falls (HP:0002359) | 1.91550062 |
| 78 | Onycholysis (HP:0001806) | 1.90710125 |
| 79 | Nail dystrophy (HP:0008404) | 1.88561348 |
| 80 | Periodontitis (HP:0000704) | 1.88069222 |
| 81 | Shallow orbits (HP:0000586) | 1.87191190 |
| 82 | EMG: myopathic abnormalities (HP:0003458) | 1.84922174 |
| 83 | Abnormal blistering of the skin (HP:0008066) | 1.84880606 |
| 84 | Difficulty running (HP:0009046) | 1.84799678 |
| 85 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.84640750 |
| 86 | Polycythemia (HP:0001901) | 1.83635991 |
| 87 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.83442062 |
| 88 | Radial bowing (HP:0002986) | 1.83291616 |
| 89 | Aneurysm (HP:0002617) | 1.82459702 |
| 90 | Ventricular arrhythmia (HP:0004308) | 1.81655852 |
| 91 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.79696572 |
| 92 | Muscle fiber inclusion bodies (HP:0100299) | 1.78466401 |
| 93 | Advanced eruption of teeth (HP:0006288) | 1.78418712 |
| 94 | Ridged nail (HP:0001807) | 1.77584833 |
| 95 | Fragile nails (HP:0001808) | 1.77498726 |
| 96 | Broad face (HP:0000283) | 1.77348377 |
| 97 | Amyloidosis (HP:0011034) | 1.77015252 |
| 98 | Gingivitis (HP:0000230) | 1.76135982 |
| 99 | Nonimmune hydrops fetalis (HP:0001790) | 1.75988900 |
| 100 | Palmoplantar hyperkeratosis (HP:0000972) | 1.75670697 |
| 101 | Abnormal foot bone ossification (HP:0010675) | 1.74772828 |
| 102 | Absent frontal sinuses (HP:0002688) | 1.74126428 |
| 103 | Rhabdomyolysis (HP:0003201) | 1.74081661 |
| 104 | Conjunctival hamartoma (HP:0100780) | 1.73093516 |
| 105 | Axonal loss (HP:0003447) | 1.72604232 |
| 106 | Ankyloglossia (HP:0010296) | 1.72476716 |
| 107 | Mucopolysacchariduria (HP:0008155) | 1.72473649 |
| 108 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.72473649 |
| 109 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.71766529 |
| 110 | Ulnar deviation of the wrist (HP:0003049) | 1.70840538 |
| 111 | Hypoplasia of dental enamel (HP:0006297) | 1.70762151 |
| 112 | Woolly hair (HP:0002224) | 1.70649787 |
| 113 | Hydroxyprolinuria (HP:0003080) | 1.70601113 |
| 114 | Abnormality of proline metabolism (HP:0010907) | 1.70601113 |
| 115 | Atrial fibrillation (HP:0005110) | 1.70598525 |
| 116 | Short nail (HP:0001799) | 1.70330384 |
| 117 | Abnormal glucose tolerance (HP:0001952) | 1.70261216 |
| 118 | Blue sclerae (HP:0000592) | 1.69811233 |
| 119 | Myoglobinuria (HP:0002913) | 1.69569307 |
| 120 | Coarse hair (HP:0002208) | 1.68040355 |
| 121 | Abnormality of macrophages (HP:0004311) | 1.67606767 |
| 122 | Soft skin (HP:0000977) | 1.67438528 |
| 123 | Skin ulcer (HP:0200042) | 1.67262772 |
| 124 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.67050421 |
| 125 | Recurrent bronchitis (HP:0002837) | 1.66703350 |
| 126 | Subacute progressive viral hepatitis (HP:0006572) | 1.66678540 |
| 127 | Gastrointestinal infarctions (HP:0005244) | 1.66371558 |
| 128 | Abnormality of T cell number (HP:0011839) | 1.66019429 |
| 129 | Elbow flexion contracture (HP:0002987) | 1.65364757 |
| 130 | Wormian bones (HP:0002645) | 1.64732802 |
| 131 | Ulnar bowing (HP:0003031) | 1.64601238 |
| 132 | Acanthosis nigricans (HP:0000956) | 1.64304235 |
| 133 | Slender build (HP:0001533) | 1.64039274 |
| 134 | Abnormality of oral frenula (HP:0000190) | 1.63968641 |
| 135 | Esophageal varix (HP:0002040) | 1.63222020 |
| 136 | Dilated cardiomyopathy (HP:0001644) | 1.62918577 |
| 137 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.62648008 |
| 138 | Hyperactive renin-angiotensin system (HP:0000841) | 1.62606731 |
| 139 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.62464302 |
| 140 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.62464302 |
| 141 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.62464302 |
| 142 | Retrobulbar optic neuritis (HP:0100654) | 1.62342854 |
| 143 | Optic neuritis (HP:0100653) | 1.62342854 |
| 144 | Abnormality of the calf musculature (HP:0001430) | 1.61609154 |
| 145 | Tetraparesis (HP:0002273) | 1.61604069 |
| 146 | Abnormality of complement system (HP:0005339) | 1.61440745 |
| 147 | Sudden death (HP:0001699) | 1.60951300 |
| 148 | Palmar hyperkeratosis (HP:0010765) | 1.60902974 |
| 149 | Nephritis (HP:0000123) | 1.59350828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 3.54658923 |
| 2 | TRIB3 | 2.84505772 |
| 3 | ERN1 | 2.28717049 |
| 4 | PKN2 | 2.27795929 |
| 5 | MAP4K1 | 2.07791083 |
| 6 | STK10 | 2.04055553 |
| 7 | NEK9 | 2.00584069 |
| 8 | TRPM7 | 1.90398730 |
| 9 | TYK2 | 1.89625763 |
| 10 | MAP3K2 | 1.85568700 |
| 11 | RIPK1 | 1.82117468 |
| 12 | TBK1 | 1.80818560 |
| 13 | JAK3 | 1.79168753 |
| 14 | MAP3K14 | 1.76916298 |
| 15 | LRRK2 | 1.72382128 |
| 16 | MAP3K3 | 1.69222788 |
| 17 | PRPF4B | 1.68775673 |
| 18 | FGFR4 | 1.68572616 |
| 19 | PDK4 | 1.67607096 |
| 20 | PDK3 | 1.67607096 |
| 21 | TESK1 | 1.63050001 |
| 22 | CDC42BPA | 1.62750489 |
| 23 | JAK1 | 1.62432926 |
| 24 | MST1R | 1.60455873 |
| 25 | TGFBR2 | 1.54632881 |
| 26 | PIK3CA | 1.42834333 |
| 27 | FGFR3 | 1.42401546 |
| 28 | TXK | 1.41654469 |
| 29 | MAP2K3 | 1.38883931 |
| 30 | ZAP70 | 1.34768302 |
| 31 | MST4 | 1.34497307 |
| 32 | PDK2 | 1.33978734 |
| 33 | MAP3K13 | 1.30908989 |
| 34 | PIM2 | 1.27914337 |
| 35 | LATS1 | 1.27009703 |
| 36 | FRK | 1.26418847 |
| 37 | EPHB1 | 1.24433857 |
| 38 | PTK6 | 1.23487162 |
| 39 | STK38 | 1.23005340 |
| 40 | MAPKAPK3 | 1.22353690 |
| 41 | RPS6KA4 | 1.22337063 |
| 42 | EPHA2 | 1.21502672 |
| 43 | DDR2 | 1.18435286 |
| 44 | LMTK2 | 1.17723084 |
| 45 | IKBKE | 1.17065349 |
| 46 | PDGFRA | 1.16831126 |
| 47 | NME2 | 1.16064123 |
| 48 | ITK | 1.15428738 |
| 49 | CSK | 1.14259604 |
| 50 | MAP3K6 | 1.13899208 |
| 51 | FLT3 | 1.10553443 |
| 52 | SIK1 | 1.10069345 |
| 53 | EPHA3 | 1.07232775 |
| 54 | MOS | 1.06147092 |
| 55 | STK3 | 1.04281373 |
| 56 | KIT | 1.03687893 |
| 57 | CAMK1D | 1.02935212 |
| 58 | KSR2 | 1.00948028 |
| 59 | MYLK | 1.00263008 |
| 60 | SCYL2 | 0.99865835 |
| 61 | MAP3K10 | 0.99751435 |
| 62 | EEF2K | 0.99430038 |
| 63 | MAP3K1 | 0.96266542 |
| 64 | KDR | 0.95966206 |
| 65 | TGFBR1 | 0.94192417 |
| 66 | PRKG2 | 0.94114454 |
| 67 | IKBKB | 0.93777943 |
| 68 | ICK | 0.93673705 |
| 69 | BLK | 0.93535837 |
| 70 | BMPR2 | 0.93401925 |
| 71 | CDK6 | 0.90529565 |
| 72 | PRKAA2 | 0.88472277 |
| 73 | PIM1 | 0.84862593 |
| 74 | BMX | 0.83401085 |
| 75 | DMPK | 0.80182876 |
| 76 | STK24 | 0.79281481 |
| 77 | OBSCN | 0.78163785 |
| 78 | PDPK1 | 0.77267262 |
| 79 | LATS2 | 0.77151181 |
| 80 | TEC | 0.77145615 |
| 81 | FER | 0.76957916 |
| 82 | PIK3CG | 0.76326502 |
| 83 | MARK3 | 0.76290349 |
| 84 | PDGFRB | 0.74534304 |
| 85 | PTK2B | 0.74439533 |
| 86 | HCK | 0.74241030 |
| 87 | MAP3K12 | 0.73056433 |
| 88 | PTK2 | 0.70662998 |
| 89 | PAK4 | 0.70582520 |
| 90 | CSF1R | 0.70523646 |
| 91 | CHUK | 0.70307033 |
| 92 | MAPK7 | 0.69562706 |
| 93 | MAPK11 | 0.68447728 |
| 94 | ARAF | 0.68358059 |
| 95 | STK4 | 0.67450167 |
| 96 | LCK | 0.66911800 |
| 97 | JAK2 | 0.64452354 |
| 98 | RIPK4 | 0.62601739 |
| 99 | CDK12 | 0.60757063 |
| 100 | RPS6KB2 | 0.60030646 |
| 101 | ROCK1 | 0.60021662 |
| 102 | MAPK12 | 0.59849949 |
| 103 | MELK | 0.59239449 |
| 104 | IRAK4 | 0.58670422 |
| 105 | PRKD2 | 0.57518394 |
| 106 | EPHB2 | 0.56743669 |
| 107 | PAK2 | 0.56340288 |
| 108 | BTK | 0.55823679 |
| 109 | AKT3 | 0.55320976 |
| 110 | FGFR1 | 0.54934223 |
| 111 | SGK3 | 0.54892525 |
| 112 | WNK1 | 0.54818413 |
| 113 | STK38L | 0.51752271 |
| 114 | MAP3K5 | 0.51678607 |
| 115 | MAP3K8 | 0.50546535 |
| 116 | ROCK2 | 0.50516009 |
| 117 | MAPKAPK2 | 0.49720321 |
| 118 | IRAK3 | 0.48734302 |
| 119 | PRKD1 | 0.48662171 |
| 120 | NUAK1 | 0.47239477 |
| 121 | MARK2 | 0.47189438 |
| 122 | RET | 0.45833763 |
| 123 | MET | 0.45731771 |
| 124 | ILK | 0.45479686 |
| 125 | PDK1 | 0.45280544 |
| 126 | GRK7 | 0.45186347 |
| 127 | MAP3K11 | 0.44764113 |
| 128 | ERBB3 | 0.42107555 |
| 129 | TAOK1 | 0.41846339 |
| 130 | NEK6 | 0.41344427 |
| 131 | HIPK2 | 0.41125468 |
| 132 | GRK6 | 0.40776111 |
| 133 | TAOK3 | 0.40232118 |
| 134 | MAP2K1 | 0.39905779 |
| 135 | MTOR | 0.39401068 |
| 136 | NLK | 0.39070918 |
| 137 | MAP3K7 | 0.38977850 |
| 138 | ERBB4 | 0.38858334 |
| 139 | ABL1 | 0.38109586 |
| 140 | BCKDK | 0.37763357 |
| 141 | ACVR1B | 0.37548701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.26423192 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.18194767 |
| 3 | Malaria_Homo sapiens_hsa05144 | 1.92192832 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85975650 |
| 5 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.79149758 |
| 6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.78413407 |
| 7 | Viral myocarditis_Homo sapiens_hsa05416 | 1.77404177 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.71442492 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.64371032 |
| 10 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.62059460 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61112388 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 1.56993598 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.56136028 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.51846251 |
| 15 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.48798663 |
| 16 | Focal adhesion_Homo sapiens_hsa04510 | 1.45945505 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.45331717 |
| 18 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.40133716 |
| 19 | Adherens junction_Homo sapiens_hsa04520 | 1.37870872 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.36887226 |
| 21 | Amoebiasis_Homo sapiens_hsa05146 | 1.36602403 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.31420076 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30862285 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.30845932 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29716118 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28423345 |
| 27 | Apoptosis_Homo sapiens_hsa04210 | 1.27392887 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.25977312 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.25830776 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.24898906 |
| 31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.23864935 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.23273069 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.22315714 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.21452839 |
| 35 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.18700111 |
| 36 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.17901236 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.15574684 |
| 38 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14134644 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.11862047 |
| 40 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.11692605 |
| 41 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.08619938 |
| 42 | Circadian rhythm_Homo sapiens_hsa04710 | 1.07941337 |
| 43 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.07311625 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.06512745 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.06219291 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02994078 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 0.99700225 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.98711304 |
| 49 | Insulin resistance_Homo sapiens_hsa04931 | 0.98337182 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 0.97202595 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94739525 |
| 52 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.94628774 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94434540 |
| 54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.90495053 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.89877263 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89870673 |
| 57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.88595263 |
| 58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.88476989 |
| 59 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87157272 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86697250 |
| 61 | Histidine metabolism_Homo sapiens_hsa00340 | 0.86631711 |
| 62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.85884888 |
| 63 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.85460226 |
| 64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.85205871 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84646737 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.84248056 |
| 67 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.83627105 |
| 68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.83028615 |
| 69 | Mineral absorption_Homo sapiens_hsa04978 | 0.82750200 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.82711557 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82701925 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.82666230 |
| 73 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.79334183 |
| 74 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.78693129 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.78257513 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.78019260 |
| 77 | Hepatitis B_Homo sapiens_hsa05161 | 0.77886634 |
| 78 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.77714443 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.77692778 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.77342768 |
| 81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76763494 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76331201 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.76106072 |
| 84 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75989196 |
| 85 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74024624 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73661185 |
| 87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72916431 |
| 88 | Renin secretion_Homo sapiens_hsa04924 | 0.72598354 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.72276838 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70109876 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69897269 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.69697854 |
| 93 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.69672803 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69137602 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68916150 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68722006 |
| 97 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68354634 |
| 98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67730622 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.67493852 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67171463 |
| 101 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.66689778 |
| 102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66292140 |
| 103 | Tight junction_Homo sapiens_hsa04530 | 0.66058845 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.65879928 |
| 105 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65544934 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64619015 |
| 107 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63716566 |
| 108 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63136562 |
| 109 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.62743349 |
| 110 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62547833 |
| 111 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.61643382 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60950115 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60659676 |
| 114 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59920356 |
| 115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59917755 |
| 116 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59209940 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58958478 |
| 118 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58760143 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58280672 |
| 120 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.56942838 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56627964 |
| 122 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.56145023 |
| 123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55998945 |
| 124 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55268258 |
| 125 | Prostate cancer_Homo sapiens_hsa05215 | 0.54893247 |
| 126 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53940747 |
| 127 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53598425 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53536560 |
| 129 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52082078 |
| 130 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51324354 |
| 131 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50315001 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50005173 |

